Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): AEF0117

            Therapeutic Area: Psychiatry/Psychology Product Name: AEF0117

            Highest Development Status: Phase II Product Type: Small molecule

            Partner/Sponsor/Collaborator: Indivior

            Deal Size: $130.0 million Upfront Cash: $30.0 million

            Deal Type: Collaboration June 08, 2021


            Indivior has entered into a strategic collaboration with Aelis Farma ("Aelis"), a private biotechnology company based in Bordeaux, France, that includes an exclusive option and license agreement (the "Agreement") for the global rights to AEF0117.